The global breast cancer brachytherapy market size is estimated to reach USD 105.3 million by 2027, expanding at a CAGR of 7.0%, according to a new report by Grand View Research, Inc. The increasing prevalence of breast cancer is expected to accelerate market growth. For instance, the Breastcancer.org reported that as of January 2020, there were more than 3.5 million women suffering from breast cancer in the U.S.
In
addition, the rising adoption of brachytherapy by academic medical
centers, oncology centers, and hospitals is expected to boost the market
growth. For instance, in October 2018, Navicent Health adopted the Xoft Axxent
Electronic Brachytherapy (eBx) System developed by iCAD, Inc. for the treatment
of breast cancer in Georgia. Furthermore, in October 2018, SUNY Upstate Medical
University also adopted the Xoft Axxent Electronic Brachytherapy (eBx) System
to provide treatment for early-stage breast cancer.
Moreover,
government hospitals in developing countries are installing advanced systems to
provide better quality treatment for their patients. For instance, in August
2018, Eckert and Ziegler BEBIG delivered and installed SagiNova HDR afterloader
at BP Koirala Memorial Cancer Hospital of Nepal. SagiNova is suitable for
interstitial breast implants. Hence, the use of such brachytherapy systems by
hospitals is expected to fuel market growth.
Market
players entering into strategic initiatives such as collaborations and
partnerships are anticipated to propel the demand over the next few years. For
instance, in July 2018, RaySearch partnered with Eckert and Ziegler BEBIG to
integrate SagiNova with the RayCare oncology information system and RayStation
treatment planning system to improve treatment outcomes during brachytherapy.
An
increase in funding initiatives for HDR units in medical centers by
organizations is estimated to drive the market. For instance, in April 2019,
OSJ Charities Trust Fund collaborated with the National Federation of Italian
Canadians to donate SagiNova for Santo Spirito Hospital as an alternative to
external beam radiation therapy for a targeted approach and shorter treatment
time.
Favorable
reimbursement policies for oncologists, surgeons, and hospitals are expected to
fuel market growth. For instance, HDR brachytherapy offers USD 11,000 as
Medicare reimbursement for five days treatment period according to the coding
issued by Centers for Medicare and Medicaid Services (CMS).
Full Research Report On Breast Cancer Brachytherapy Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/breast-cancer-brachytherapy-market
Breast Cancer
Brachytherapy Market Report Highlights
- HDR
brachytherapy dominated the market in 2019 and is also projected to be the
fastest-growing technology segment over the forecast period
- Factors such
as rapid delivery of radiation, accuracy, and precise tumor-specific dose
delivery in a shorter period of time are expected to drive the segment
- North America
has dominated the market in 2019 owing to the presence of key players and
increasing adoption of the therapy by oncology centers and hospitals
- In Asia
Pacific, the market is estimated to grow fast over the forecast period due
to high unmet needs and growth opportunities for investors and companies
to expand their presence in the region.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/breast-cancer-brachytherapy-market/request/rs1
Breast Cancer
Brachytherapy Market Segmentation
Grand View Research has
segmented the global breast cancer brachytherapy market on the basis of
technology and region:
Breast Cancer
Brachytherapy Technology Outlook (Revenue, USD Million, 2016 - 2027)
- High Dose Rate (HDR) Brachytherapy
- Low Dose Rate (LDR) Brachytherapy
Breast Cancer
Brachytherapy Regional Outlook (Revenue, USD Million, 2016 - 2027)
- North America
- The U.S.
- Canada
- Europe
- Germany
- The U.K.
- France
- Italy
- Spain
- Russia
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Singapore
- Latin America
- Brazil
- Mexico
- Argentina
- MEA
- South Africa
- Saudi Arabia
- United Arab Emirates
List of Key
Players of Breast Cancer Brachytherapy Market
- Eckert & Ziegler BEBIG
- Elekta AB
- Varian Medical Systems, Inc.
- ICAD, INC.
- Hologic, Inc.
- Cianna Medical
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment